Maintenance Therapy for Lupus Nephritis — Something Old, Something New
- 4 March 2004
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 350 (10) , 1044-1046
- https://doi.org/10.1056/nejme048010
Abstract
From a historical perspective, there are few diseases for which the cause, natural history, and response to treatment have been as complex or difficult to define as those of systemic lupus erythematosus (SLE). In large part, this is because SLE represents a clinical syndrome rather than a unique disease entity. The apparent diversity of pathogenic mechanisms operating in individual patients, which parallels the diversity observed in various animal models of SLE, underscores the fact that the disease phenotype arises from a variable mixture of environmental factors, the hormonal milieu, genes that contribute to an autoimmune diathesis, and other causes of . . .Keywords
This publication has 7 references indexed in Scilit:
- Sequential Therapies for Proliferative Lupus NephritisNew England Journal of Medicine, 2004
- The nature and outcome of infection in systemic lupus erythematosusLupus, 2002
- Efficacy of Mycophenolate Mofetil in Patients with Diffuse Proliferative Lupus NephritisNew England Journal of Medicine, 2000
- Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black AmericansKidney International, 1997
- Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritisThe Lancet, 1992
- Therapy of Lupus NephritisNew England Journal of Medicine, 1986
- Treatment of Diffuse Proliferative Lupus Nephritis with Prednisone and Combined Prednisone and CyclophosphamideNew England Journal of Medicine, 1978